Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126095351 | 12609535 | 1 | I | 20160106 | 20160125 | 20160801 | 20160801 | PER | US-TEVA-629308USA | TEVA | 35.81 | YR | F | Y | 61.29000 | KG | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126095351 | 12609535 | 1 | PS | BACLOFEN. | BACLOFEN | 1 | Unknown | 72234 | 10 | MG | |||||||||
| 126095351 | 12609535 | 2 | SS | SOMA | CARISOPRODOL | 1 | Unknown | 1000 MILLIGRAM DAILY; | WP5901 | 0 | 250 | MG | QID | ||||||
| 126095351 | 12609535 | 3 | SS | KLONOPIN | CLONAZEPAM | 1 | Unknown | 1 MILLIGRAM DAILY; | 0 | .5 | MG | TABLET | BID | ||||||
| 126095351 | 12609535 | 4 | C | SKELAXIN | METAXALONE | 1 | Unknown | 800 MILLIGRAM DAILY; | 0 | 800 | MG | TABLET | QD | ||||||
| 126095351 | 12609535 | 5 | C | SKELAXIN | METAXALONE | 1 | 0 | ||||||||||||
| 126095351 | 12609535 | 6 | C | SKELAXIN | METAXALONE | 1 | 0 | ||||||||||||
| 126095351 | 12609535 | 7 | C | ADDERALL XR | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | 60 MILLIGRAM DAILY; | 0 | 30 | MG | CAPSULE | BID | |||||||
| 126095351 | 12609535 | 8 | C | NEURONTIN | GABAPENTIN | 1 | 2400 MILLIGRAM DAILY; | 0 | 800 | MG | TABLET | TID | |||||||
| 126095351 | 12609535 | 9 | C | NEURONTIN | GABAPENTIN | 1 | 1600 MILLIGRAM DAILY; | 0 | 400 | MG | CAPSULE | QID | |||||||
| 126095351 | 12609535 | 10 | C | COGENTIN | BENZTROPINE MESYLATE | 1 | 1 MILLIGRAM DAILY; | 0 | 1 | MG | TABLET | QD | |||||||
| 126095351 | 12609535 | 11 | C | ATIVAN | LORAZEPAM | 1 | Intramuscular | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126095351 | 12609535 | 1 | Muscle spasms |
| 126095351 | 12609535 | 2 | Tremor |
| 126095351 | 12609535 | 3 | Nervousness |
| 126095351 | 12609535 | 4 | Dystonia |
| 126095351 | 12609535 | 5 | Post-traumatic stress disorder |
| 126095351 | 12609535 | 6 | Complex regional pain syndrome |
| 126095351 | 12609535 | 7 | Attention deficit/hyperactivity disorder |
| 126095351 | 12609535 | 8 | Neuralgia |
| 126095351 | 12609535 | 9 | Neuralgia |
| 126095351 | 12609535 | 10 | Dystonia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126095351 | 12609535 | Drug ineffective | |
| 126095351 | 12609535 | Fatigue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126095351 | 12609535 | 1 | 2015 | 2015 | 0 | |
| 126095351 | 12609535 | 2 | 20160106 | 0 | ||
| 126095351 | 12609535 | 3 | 2006 | 0 | ||
| 126095351 | 12609535 | 4 | 2009 | 0 | ||
| 126095351 | 12609535 | 8 | 2009 | 0 | ||
| 126095351 | 12609535 | 10 | 201510 | 0 |